| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421210A2 Method of detecting protease activity in a cell |
| 05/26/2004 | EP1421193A2 Novel metabolism-associated gene products of ashbya gossypii |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1421182A1 Methods of inducing differentiation of stem cells |
| 05/26/2004 | EP1421181A1 ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES |
| 05/26/2004 | EP1421180A2 Method of treating systemic inflammatory response syndrome |
| 05/26/2004 | EP1421179A1 Isolation of cells from neural cell populations using antibodies to fa1/dlk1 |
| 05/26/2004 | EP1421177A2 Zinc finger binding domains for cnn |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421173A2 Method and device for the in vitro cultivation of cells |
| 05/26/2004 | EP1421172A2 Artificial synapse chip interface for electronic prosthetic retina |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421097A2 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 05/26/2004 | EP1420823A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420807A1 Platelet-derived growth factor protection of cardiac myocardium |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP0995121B1 C-peptide specific assay procedure |
| 05/26/2004 | EP0805851B1 Binary bac vector |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500147A Improved gene expression |
| 05/26/2004 | CN1500142A High level cytokine prodn. with enhanced cell viability |
| 05/26/2004 | CN1500141A Gene targeting methods and vectors |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1499980A Agents promoting proliferation and/or differentiation of hematopoietic stem cells and/or hematopoietic precursor cells |
| 05/26/2004 | CN1499978A Manufacture of hemoglobin-based oxygen carrier |
| 05/26/2004 | CN1499976A Caloporoside derivatives, methods for prodn. thereof and their use |
| 05/26/2004 | CN1498967A Method for inserting into gene of eucaryote cell at fixed point and/or tapping out is as well as dedicated carrier |
| 05/26/2004 | CN1498966A Promotor of gene of cytoplasm type 1,6 diphosphate fructose enzyme and its application |
| 05/26/2004 | CN1151263C Overxpression of desired proteins in eukaryotic cells mediated by cyclin D1 overexpression |
| 05/26/2004 | CN1151258C Prodn. of erythropoietin by endogenous gene activation |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/25/2004 | US6740749 A nucleic acid sequence from grapevine (vitis vinifera) |
| 05/25/2004 | US6740739 Substitutional variants of APO-2 ligand |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740737 Cardiovascular system associated protein kinase 2 (CSAPK-2) antibodies |
| 05/25/2004 | US6740523 Administering 14-3-3 sigma protein for suppressing growth of tumor cells |
| 05/25/2004 | US6740522 Rank (receptor activator of neurotrophic factor-kappa b) ligand (rankl) polypeptides; immunoregulatory activity |
| 05/25/2004 | US6740521 Cells for use as tools in the analysis and detection of environmental pollutants |
| 05/25/2004 | US6740520 Cytokine receptor and nucleic acids encoding the same |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740511 Comprising mutations at one or more residues within the region of fiber stretching; used in gene therapy |
| 05/25/2004 | US6740505 Culturing eukaryotic cells which produce proteins in a medium which comprises an alkanoic acid and/or salt at a maintained concentration |
| 05/25/2004 | US6740503 By illegitimate recombination of a regulatory sequence; identification, activation, isolation, and/or expression of genes without need for target sequence during integration |
| 05/25/2004 | US6740493 Quantifying the amount of osteocalcin/osteonectin to identify bone disorder risk; useful in the treatment of bone disorders and diseases, such as osteoporosis, and in promoting fracture repair |
| 05/25/2004 | US6740490 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with cd antigens; animal husbandry |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/22/2004 | CA2448515A1 Compositions and methods for identifying thymidylate synthase modulators |
| 05/21/2004 | WO2004042393A1 Medium and method for measuring the efficacy of a tumour therapy |
| 05/21/2004 | WO2004042041A1 A means of producing and utilising a population of disease specific cytotoxic t-lymphoctyes |
| 05/21/2004 | WO2004042040A1 Expansion agents for stem cells |
| 05/21/2004 | WO2004042039A1 Induction of ctla-4 upregulation in t lymphocytes |
| 05/21/2004 | WO2004042038A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 05/21/2004 | WO2004042035A2 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 05/21/2004 | WO2004042033A2 Circulating stem cells and uses related thereto |
| 05/21/2004 | WO2004042027A2 Allele-specific rna interference |
| 05/21/2004 | WO2004042023A2 Stem cell libraries |
| 05/21/2004 | WO2004042018A2 Dopamine neurons from human embryonic stem cells |
| 05/21/2004 | WO2004042010A2 Modified luciferase nucleic acids and methods of use |
| 05/21/2004 | WO2004042007A2 Somatic cell gene targeting vectors and methods of use thereof |
| 05/21/2004 | WO2004042004A2 Mouse model for autoimmune disorders |
| 05/21/2004 | WO2004041183A2 Methods of treating pulmonary fibrotic disorders |
| 05/21/2004 | WO2004041076A2 Methods of detecting colorectal cancer |
| 05/21/2004 | WO2004041061A2 Substrates, devices, and methods for cellular assays |
| 05/21/2004 | WO2004040973A2 Organellar targeting of rna and its use in the interruption of environmental gene flow |
| 05/21/2004 | WO2004029211A3 Frozen spermatozoa compositions and uses thereof |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004019872A3 Oral delivery of modified transferrin fusion proteins |
| 05/21/2004 | WO2004018652A3 Method for obtaining diploid, pluripotential stem cells and use thereof |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003102215A3 Methods of identifying and isolating stem cells and cancer stem cells |
| 05/21/2004 | WO2003080638A3 Antisense iap nucleobase oligomers and uses thereof |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003063802A9 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003050275A8 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/21/2004 | WO2003050249B1 Islet cells from human embryonic stem cells |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2003013422A3 Methods for the treatment and prognosis of leukemia and other cancer types |
| 05/21/2004 | WO2003004684A3 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES |